Forward Pharma A/S American Depositary Shares
FWP was delisted on the 27th of December, 2022.
13 hedge funds and large institutions have $7.68M invested in Forward Pharma A/S American Depositary Shares in 2018 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 1 closing their positions.
500% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 1
44% more funds holding
Funds holding: 9 → 13 (+4)
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
62% less capital invested
Capital invested by funds: $20M → $7.68M (-$12.3M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NM
Newtyn Management
New York
|
+$1.53M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$44.3K |
| 3 |
Morgan Stanley
New York
|
+$42.2K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$33.4K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$3.94K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
-$43K |
| 2 |
Renaissance Technologies
New York
|
-$35.5K |
| 3 |
BI
BVF Inc
San Francisco,
California
|
-$32.9K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$3.4K |
| 5 |
PCG
Private Capital Group
West Hartford,
Connecticut
|
-$182 |
FWP Hedge Fund Activity: Q4 2018 in Review
13 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Forward Pharma A/S American Depositary Shares (FWP) for Q4 2018, worth a combined $7.68M — down 62% from $20M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new FWP positions and 1 closed out — a net gain of 5 holders — while 2 added to existing stakes and 4 trimmed.
The largest buyer was Newtyn Management, opening a new position worth an estimated $1.53M. The largest seller was Acadian Asset Management, exiting entirely with an estimated $43K sold.
- 13 institutional investors held Forward Pharma A/S American Depositary Shares (FWP) as of Q4 2018, up from 9 in Q3 2018.
- Funds reported $7.68M of Forward Pharma A/S American Depositary Shares stock for Q4 2018, down 62% quarter-over-quarter.
- 6 funds opened new Forward Pharma A/S American Depositary Shares positions in Q4 2018 and 1 closed out, a net change of +5 holders.
- The largest Forward Pharma A/S American Depositary Shares buyer in Q4 2018 was Newtyn Management, an estimated $1.53M added.
- The largest Forward Pharma A/S American Depositary Shares seller in Q4 2018 was Acadian Asset Management, an estimated $43K sold.
Based on aggregated 13F filings for Q4 2018.